Regulation of intercalated cell function by the mineralocorticoid receptor
Regulation of intercalated cell function by the mineralocorticoid receptor
批准号:
10078997
负责人:
SUSAN MARIE WALL
金额:
$39.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-15 至 2022-12-31
关键词:
AblationAcidsActinsAddressAldosteroneAngiotensin IIAnimalsApicalAttenuatedBicarbonatesBindingBlood PressureCardiovascular DiseasesCell NucleusCell membraneCell physiologyCellsCytoskeletal ModelingCytoskeletal ProteinsDataDietDuct (organ) structureEpidemicEquilibriumFamilyGene ExpressionGenesGenetic TranscriptionGlucocorticoidsGuanosine Triphosphate PhosphohydrolasesHumanHypertensionHypokalemiaImmunohistochemistryIn VitroIndustrializationIntakeIntercalated CellIon TransportKidneyKidney DiseasesKnockout MiceLigand BindingMediatingMicroscopyMineralocorticoid ReceptorMinorityModelingMolecularMusProtein DephosphorylationPublishingReceptor ActivationReceptor GeneReceptor SignalingRegulationRenal tubule structureRodent ModelRoleSignal TransductionSodium ChlorideTestingTimeWorkabsorptionapical membranebaseblood pressure regulationcardiovascular risk factorcell typecytochemistryepithelial Na+ channelextracellularin vivoinhibitor/antagonistpreventpublic health relevancereceptorresponserhorho GTP-Binding Proteinssalt balancesalt sensitive hypertensionuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. PROJECT SUMMARY AND RELEVANCE:
While Na+ intake exacerbates hypertension, blood pressure also rises with increased Cl- intake,
independently of Na+, making Cl- intake and renal Cl- absorption critical in blood pressure regulation.
Aldosterone administration in vivo increases NaCl uptake by the cortical collecting duct (CCD) primarily
through principal cell-mediated Na+ absorption and intercalated cell-mediated Cl- absorption, which occurs in
exchange for HCO3-, largely through the Cl-/HCO3- exchanger, pendrin. How Cl- contributes to hypertension
and, in particular, how aldosterone stimulates IC Cl-/HCO3- exchange is poorly understood.
Aldosterone’s signaling mechanism in principal cells is well established. 11 HSD2 metabolizes cellular
glucocorticoids enabling aldosterone binding to the MR (Nr3c2), thereby stimulating ENaC. However,
published and preliminary data show that the signaling mechanism(s) of aldosterone and the MR are very
different in ICs. First, 11 HSD2 is not expressed in ICs. Second, MR inhibitors reduce IC transporter
abundance even in the known absence of aldosterone. Third, published and preliminary data show
angiotensin II and a high NaCl diet can activate the MR independently of aldosterone, likely through a
mechanism involving Rac1, a GTPase in the Rho family, that regulates cytoskeletal reorganization and gene
expression. We observed that Rac1 gene ablation or Rac1 inhibition reduces pendrin abundance in
angiotensin II-treated mice. We observed that increased NaCl intake reduces Cl- absorption and Cl- transporter
abundance in CCDs from untreated mice, but increases the apical plasma membrane abundance of
intercalated cell Cl- transporters in angiotensin II-treated mice. We therefore hypothesize that IC MR activation
occurs through or independently of aldosterone. We also hypothesize that angiotensin II-induced IC MR
activation occurs through Rac1 and the MR, which act a molecular switch, by which the effect of NaCl intake IC
Cl- transporter abundance and function (IC Cl-/HCO3- exchange) changes from inhibitory to stimulatory. To
study IC transporter regulation by the IC MR, we developed mice lacking the mineralocorticoid receptor and
Rac1 in intercalated cells (IC MR KO and IC Rac1 KO mice). Determining how aldosterone and angiotensin II
target intercalated cells may provide additional targets for hypertension.
Proposal Aims are to determine: 1) if the mineralocorticoid receptor modulates intercalated cell
transporter abundance and function, blood pressure and salt balance, 2) if the mineralocorticoid receptor
stimulates intercalated cell function independently of aldosterone or aldosterone binding and 3) If angiotensin II
acts through the MR and Rac1 to modulate the effect of NaCl intake on IC transporter abundance and function.
We will examine the effect of K+, aldosterone, angiotensin II and the MR on intercalated cell transporter
abundance and function in vivo and in vitro with quantitative real time PCR, immunohistochemistry,
immunogold cytochemistry, renal tubules perfused in vitro and in whole animal studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Atlanta Network for Training In KUH Scientific Research (ATLANTIS)
-
批准号:10705255
-
项目类别:
-
资助金额:$48.59万
-
财政年份:2022
-
负责人:SUSAN MARIE WALL
-
依托单位:
Atlanta Network for Training In KUH Scientific Research (ATLANTIS)
-
批准号:10654944
-
项目类别:
-
资助金额:$74.75万
-
财政年份:2022
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of intercalated cell function by the mineralocorticoid receptor
-
批准号:10319975
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2019
-
负责人:SUSAN MARIE WALL
-
依托单位:
Interaction of NEDD4-2 and Aldosterone in Intercalated Cell Function
-
批准号:9284447
-
项目类别:
-
资助金额:$33.13万
-
财政年份:2015
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of Pendrin by Angiotensin II
-
批准号:7988978
-
项目类别:
-
资助金额:$10.31万
-
财政年份:2009
-
负责人:SUSAN MARIE WALL
-
依托单位:
The Role of Pendrin in Mineralocorticoid-Induced Hypertension
-
批准号:7471478
-
项目类别:
-
资助金额:$25.62万
-
财政年份:2007
-
负责人:SUSAN MARIE WALL
-
依托单位:
The Role of Pendrin in Mineralocorticoid-Induced Hypertension
-
批准号:6866957
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2004
-
负责人:SUSAN MARIE WALL
-
依托单位:
Renal Physiology of Pendrin
-
批准号:6437988
-
项目类别:
-
资助金额:$10.18万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Renal Physiology of Pendrin
-
批准号:6781779
-
项目类别:
-
资助金额:$29.07万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of Pendrin by Angiotensin II
-
批准号:8135539
-
项目类别:
-
资助金额:$38.75万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of Pendrin by Angiotensin II
-
批准号:7616502
-
项目类别:
-
资助金额:$38.38万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
NH4+ TRANSPORT IN RENAL INNER MEDULLARY COLLECTING DUCT
-
批准号:6177724
-
项目类别:
-
资助金额:$17.74万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Renal Physiology of Pendrin
-
批准号:6720502
-
项目类别:
-
资助金额:$22.35万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of Pendrin by Angiotensin II
-
批准号:7455416
-
项目类别:
-
资助金额:$38.25万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Renal Physiology of Pendrin
-
批准号:6621959
-
项目类别:
-
资助金额:$29.07万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Renal Physiology of Pendrin
-
批准号:6927239
-
项目类别:
-
资助金额:$29.07万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
NH4+ TRANSPORT IN RENAL INNER MEDULLARY COLLECTING DUCT
-
批准号:2749629
-
项目类别:
-
资助金额:$16.72万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
NH4+ TRANSPORT IN RENAL INNER MEDULLARY COLLECTING DUCT
-
批准号:2383154
-
项目类别:
-
资助金额:$12.96万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
NH4+ TRANSPORT IN RENAL INNER MEDULLARY COLLECTING DUCT
-
批准号:6552490
-
项目类别:
-
资助金额:$3.05万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
Regulation of Pendrin by Angiotensin II
-
批准号:7388645
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1997
-
负责人:SUSAN MARIE WALL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: